Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: August 2011

2 - Epilepsy beginning in infancy


1. Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia 1996; 37: 19–23.
2. Sheth RD, Bodensteiner JB. Effective utilization of home-video recordings for the evaluation of paroxysmal events in pediatrics. Clin Pediatr 1994; 33: 578–82.
3. Berrington de González A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169: 2071–7.
4. Wolf B. Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab 2010; 100: 6–13.
5. Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133: 655–70.
6. Basura GJ, Hagland SP, Wiltse AM, Gospe SM Jr. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry. Eur J Pediatr 2009; 168: 697–704.
7. Kellaway P, Hrachovy RA, Frost JD Jr, Zion T. Precise characterization and quantification of infantile spasms. Ann Neurol 1979; 6: 214–18.
8. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005; 95: 71–102.
9. Arzimanoglu A. Dravet syndrome: from electroclinical characteristics to molecular biology. Epilepsia 2009; 50(Suppl 8): 3–9.
10. Scheffer IE, Zhang YH, Jansen FE, Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev 2009; 31: 394–400.
11. Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia 1995; 36: 1017–24.
12. Caraballo RH, Fontana E, Darra F, et al. Migrating focal seizures in infancy: analysis of the electroclinical patterns in 17 patients. J Child Neurol 2008; 23: 497–506.
13. Specchio N, Vigevano F. The spectrum of benign infantile seizures. Epilepsy Res 2006; 70: (Suppl 1): S156–67.
14. Dravet C, Bureau M. Benign myoclonic epilepsy in infancy. Adv Neurol 2005; 95: 127–37.
15. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion. Epileptic Disord 2007; 9: 353–412.
16. Bryant AE 3rd, Dreifuss FE. Valproic acid hepatic fatalities. III. US experience since 1986. Neurology 1996; 46: 465–9.
17. Bicknese AR, May W, Hickey WF, Dodson WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 1992; 32: 767–75.
18. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev 2008 Oct 8; 4: CD001770.
19. Kälviäinen R, Nousiainen I. Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs 2001; 15: 217–30.
20. Wild JM, Chiron C, Ahn H, et al. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS Drugs 2009; 23: 965–82.
21. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome dedicated trial. STICLO study group. Lancet 2000; 356: 1638–42.
22. Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998; 39: 508–12.
23. Eisermann MM, DeLaRailliere A, Dellatolas G, et al. Infantile spasms in Down syndrome – effects of delayed anticonvulsive treatment. Epilepsy Res 2003; 55: 21–7.
24. Saneto RP, Wyllie E. Epilepsy surgery in infancy. Semin Pediatr Neurol 2000; 7: 187–93.
25. Yang TF, Wong TT, Kwan SY, et al. Quality of life and life satisfaction in families after a child has undergone corpus callostomy. Epilepsia 1996; 37: 76–80.
26. Zamponi N, Rychlicki F, Corpaci L, Cesaroni E, Trignani R. Vagus nerve stimulation (VNS) is effective in treating catastrophic epilepsy in very young children. Neurosurg Rev 2008; 31: 291–7.
27. Kossoff EH, Rho JM. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics 2009; 6: 406–14.
28. Kossoff EH, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006; 47: 421–4.
29. Pfeifer HH, Thiele EA. Low glycaemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005; 65: 1810–2.
30. Kossoff EH, Hedderick EF, Turner Z, Freeman JM. A case−control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia 2008; 49: 1504–9.
31. Riikonen R. Long-term outcome of patients with West syndrome. Brain Dev 2001; 23: 683–7.
32. Riikonen RS. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol 2010; 14: 13–18.